KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Novavax (NVAX) Long-Term Debt Repayments: 2012-2023

Historic Long-Term Debt Repayments for Novavax (NVAX) over the last 4 years, with Mar 2023 value amounting to $325.0 million.

  • Novavax's Long-Term Debt Repayments was N/A to $325.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $325.1 million, marking a year-over-year change of. This contributed to the annual value of $325.0 million for FY2023, which is N/A change from last year.
  • Latest data reveals that Novavax reported Long-Term Debt Repayments of $325.0 million as of Q1 2023, which was up 1,710,426.32% from $19,000 recorded in Q2 2017.
  • In the past 5 years, Novavax's Long-Term Debt Repayments registered a high of $325.0 million during Q1 2023, and its lowest value of $325.0 million during Q1 2023.
  • Its 1-year average for Long-Term Debt Repayments is $325.0 million, with a median of $325.0 million in 2023.